Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

RITE AID CORPORATION (RAD)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Rite Aid March Same-Store Sales Rose 3.6%

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/05/2012 | 03:02pm CEST

Rite Aid Corp.'s (>> Rite Aid Corporation) same-store sales rose 3.6% in March, continuing a streak of monthly growth for the drugstore chain.

The No. 3 U.S. drugstore chain behind Walgreen Co. (WAG) and CVS Caremark Corp. (>> CVS Caremark Corporation) reported same-store sales growth in all but one month during 2011; March 2011 had a 0.1% drop. Last month Rite Aid reported its fourth-quarter same-store sales rose 3%, its best showing in five years.

Analysts have been expecting Rite Aid and CVS to gain market share as a result of Walgreen's exiting pharmacy benefits manager Express Scripts Holding Co.'s (ESRX) network late last year. The move was expected to result in some of Walgreen's customers going to competitors such as Rite Aid to fill prescriptions.

During March, same-store sales were up 4.6% in the front of the store.

Pharmacy same-store sales increased 3.2%, despite a negative impact of 2.4 percentage points from generic drug introductions. Same-store prescription counts grew 2.6%.

Total March drugstore sales rose 3.1% to $1.99 billion. Prescription sales accounted for 69.2% of drugstore sales.

Rite-Aid, which has about 4,659 stores, has posted losses since its 2007 acquisition of the Brooks and Eckerd chain stores that saddled it with debt just before consumers slashed spending.

The company in December reported that its fiscal third-quarter loss narrowed on higher same-store sales as the drugstore chain's wellness and loyalty and flu-immunization programs lifted pharmacy-department sales.

Shares were up 2.3% at $1.75 in recent premarket trading.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; [email protected]

Stocks mentioned in the article : Rite Aid Corporation, CVS Caremark Corporation
Stocks mentioned in the article
ChangeLast1st jan.
CVS HEALTH CORPORATION 1.55% 72.18 Delayed Quote.-2.39%
RITE AID CORPORATION 2.54% 2.02 Delayed Quote.2.54%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
06/23RITE AID : Gunman demands drugs from Rite Aid in Harrison Twp.
AQ
06/21RITE AID CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/21RITE AID : Schedules Special Stockholder Meeting for August 9, 2018 to Vote on t..
BU
06/21RITE AID : Florence Boulevard Rite Aid closes
AQ
06/19HEALTH DIALOG : Joins Clinical, Business and Government Leaders to Discuss Best ..
BU
06/18RITE AID : to Release First Quarter Results on June 27
BU
06/17RITE AID : Car crashes into Rite Aid
AQ
06/15FOLLOW-UP OPEN LETTER TO RITE AID CO : Contact: Chris Komatinsky Individual Sha..
AQ
06/15WAL MART STORES : Columbia County seeks financial transaction card fraud suspect
AQ
06/14Drugstore Chains Adapt New Real Estate Strategies to Compete with Online Sell..
AQ
More news
News from SeekingAlpha
06/23STOCKS TO WATCH : More Trade Tiffs And Stress Tests 
06/19Merger Arbitrage Mondays - June 18, 2018 
06/12Will The Rite Aid - Albertsons Merger Fall Apart? 
06/05Albertsons expected to increase cash portion of Rite Aid bid 
05/18AMAZON GO : Stores Worth Less Than Tech 
Financials ($)
Sales 2019 21 645 M
EBIT 2019 208 M
Net income 2019 -36,9 M
Debt 2019 2 221 M
Yield 2019 -
P/E ratio 2019 -
P/E ratio 2020 26,93
EV / Sales 2019 0,20x
EV / Sales 2020 0,19x
Capitalization 2 156 M
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 2,00 $
Spread / Average Target -0,99%
EPS Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kermit R. Crawford President & Chief Operating Officer
Darren W. Karst Chief Financial & Administrative Officer, SEVP
Steve Rempel Chief Information Officer & Senior Vice President
Joseph B. Anderson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION2.54%2 156
RAIA DROGASIL-25.52%5 940
PALTAC CORP21.18%3 668
AIN HOLDINGS INC24.93%2 711
GALENICA AG4.80%2 641
PETMED EXPRESS INC0.59%943